Evidence map›Paper›PMID 29171427›Full record

ArticleNeural regeneration research2017

Baicalin protects neonatal rat brains against hypoxic-ischemic injury by upregulating glutamate transporter 1

Zhi-Qing Zhou, Yong-Liang Li, Zhen-Bo Ao, Zhi-Li Wen, Qi-Wen Chen, Zheng-Gang Huang, Bing Xiao, Xiao-Hua Yan

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Current pharmaceutical biotechnology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Zhi-Qing ZhouDepartment of Pediatrics, the Second People's Hospital of Huaihua City, Huaihua, Hunan Province, China.
Yong-Liang LiDepartment of Oncology, the Second People's Hospital of Huaihua City, Huaihua, Hunan Province, China.
Zhen-Bo AoDepartment of Pediatrics, the Second People's Hospital of Huaihua City, Huaihua, Hunan Province, China.
Zhi-Li WenDepartment of Gastroenterology, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Qi-Wen ChenDepartment of Pediatrics, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Zheng-Gang HuangDepartment of Pediatrics, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Provi nce, China.
Bing XiaoDepartment of Neurosurgery, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Xiao-Hua YanDepartment of Pediatrics, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CNXian Yang Central Hospital · CNFirst Affiliated Hospital of Nanchang University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baicalin is a flavonoid compound extracted from Scutellaria baicalensis root. Recent evidence indicates that baicalin is neuroprotective in models of ischemic stroke. Here, we investigate the neuroprotective effect of baicalin in a neonatal rat model of hypoxic-ischemic encephalopathy. Seven-day-old pups underwent left common carotid artery ligation followed by hypoxia (8% oxygen at 37°C) for 2 hours, before being injected with baicalin (120 mg/kg intraperitoneally) and examined 24 hours later. Baicalin effectively reduced cerebral infarct volume and neuronal loss, inhibited apoptosis, and upregulated the expression of p-Akt and glutamate transporter 1. Intracerebroventricular injection of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) inhibitor LY294002 30 minutes before injury blocked the effect of baicalin on p-Akt and glutamate transporter 1, and weakened the associated neuroprotective effect. Our findings provide the first evidence, to our knowledge that baicalin can protect neonatal rat brains against hypoxic-ischemic injury by upregulating glutamate transporter 1 via the PI3K/Akt signaling pathway.

Indexed as

apoptosisbaicalinexcitotoxicityglutamate transporter 1hypoxia ischemianeonatal ratsnerve regenerationnerve regeneration; baicalin; hypoxia ischemia; PI3K/Akt signaling pathway; glutamate transporter 1; excitotoxicity; neonatal rats; apoptosis; neural regenerationneural regenerationPI3K/Akt signaling pathway

Identifiers

PMID29171427
PMCPMC5696843
OpenAlexW2766661284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.